Related Experiment Video

Updated: Jun 28, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53

S-H Min1, D M Kim, Y-S Heo

  • 1Department of Biological Sciences, Biomedical Research Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.

Oncogene
|November 11, 2008
PubMed

Insights

Researchers identified Phosphatase of regenerating liver 1 (PRL-1) as a new oncogenic p53 target. PRL-1 downregulates p53 protein levels, promoting tumor development through a negative feedback loop.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Biology

Background:

  • p53 is a critical tumor suppressor regulating apoptosis, differentiation, and cell cycle arrest.
  • Oncogenes like MDM2, COP1, and PIRH2 downregulate p53 via negative feedback, contributing to tumor development.
  • The role of Phosphatase of regenerating liver 1 (PRL-1) in cancer progression and its relationship with p53 remains largely unexplored.

Purpose of the Study:

  • To investigate the functional role of PRL-1 as a p53 target gene.
  • To elucidate the mechanism by which PRL-1 influences p53 protein levels and activity.
  • To determine the implications of the PRL-1/p53 interaction in cancer development and metastasis.

Main Methods:

  • Utilized small interfering RNA (siRNA) to ablate PRL-1 expression.
  • Assessed endogenous and exogenous p53 protein levels.
  • Investigated p53 ubiquitination and proteasomal degradation pathways.
  • Analyzed PRL-1's effect on p53-mediated apoptosis.
  • Examined the transcriptional regulation of PRL-1 by p53.
  • Studied the involvement of PIRH2 and MDM2 phosphorylation via Akt signaling.

Main Results:

  • PRL-1 overexpression reduced p53 protein levels and inhibited p53-mediated apoptosis.
  • PRL-1 ablation using siRNA increased p53 protein levels.
  • PRL-1 downregulates p53 through enhanced ubiquitination and proteasomal degradation.
  • PRL-1 induces p53 downregulation by upregulating PIRH2 and promoting MDM2 phosphorylation via Akt signaling.
  • PRL-1 gene contains a p53 response element, indicating p53-mediated transcriptional regulation.

Conclusions:

  • PRL-1 is a novel oncogenic p53 target gene.
  • PRL-1 contributes to tumor development by downregulating p53 through a negative feedback mechanism.
  • The findings reveal a new regulatory axis involving PRL-1 and p53 with potential implications for cancer therapy.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...